한글목차

세계의 이부프로펜 시장은 2024년에 5억 3,445만 달러로 평가되었고, 2030년까지는 7억 3만 달러에 이를것으로 예측되며, CAGR 4.80%로 성장할 전망입니다.

비스테로이드성 항염증제(NSAID)로 널리 사용됩니다. 정제, 캡슐, 시럽, 외용제 등 다양한 제형으로 공급되는 이부프로펜은 처방약과 일반 의약품 모두에서 접근성이 높아 주요 치료 옵션으로 자리 잡았습니다. 시장 성장은 만성 통증과 노화 관련 질환의 발생률 증가, 특히 노인 인구에서 두드러집니다. 전 세계적으로 기대수명이 연장됨에 따라 안전하고 신뢰할 수 있으며 비용 효율적인 진통제에 대한 수요가 증가하고 있습니다. 제조 환경은 글로벌 및 지역 기업들이 활성 제약 성분(API) 생산과 완제 의약품 개발에 참여하며 치열한 경쟁을 벌이고 있어 가격에 민감한 시장 환경을 형성하고 있습니다.

주요 시장 성장 촉진요인

의료 산업의 성장

주요 시장 과제

안전성과 부작용에 대한 우려

주요 시장 동향

전자 약국(E-Pharmacy)의 확장

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 이부프로펜 시장에 대한 COVID-19의 영향

제5장 세계의 이부프로펜 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 제품 유형별(정제, 캡슐, 시럽, 주사제)
  • 용도별(류마티스 관절염, 강직성 척추염, 염증성 질환, 월경통, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 이부프로펜 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 이부프로펜 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 이부프로펜 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 이부프로펜 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 이부프로펜 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병과 인수
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 유행, 무역 장벽

제14장 세계의 이부프로펜 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제16장 경쟁 구도

• Novartis AG
• Pfizer Inc.
• Abbott Laboratories Inc.
• Gilead Sciences Inc.
• Merck KGaA
• Astellas Pharma Inc.
• Glenmark Pharmaceuticals Ltd.
• NATCO Pharma Ltd.
• Basilea Pharmaceutical AG
• Leadiant Biosciences Inc.

제17장 전략적 제안

제18장 기업 소개 및 면책사항

영문목차

The Global Ibuprofen Market was valued at USD 534.45 Million in 2024 and is projected to reach USD 700.03 Million by 2030, growing at a CAGR of 4.80%. Ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID), is recognized for its affordability and effectiveness in managing pain, fever, and inflammation across various therapeutic areas including arthritis, menstrual cramps, dental issues, and the common cold. Available in several formulations such as tablets, capsules, syrups, and topical applications, ibuprofen's accessibility makes it a go-to treatment option for both prescription and over-the-counter use. The market's growth is driven by the increasing incidence of chronic pain and age-related disorders, particularly in the elderly population. As life expectancy rises globally, so does the demand for safe, reliable, and cost-effective analgesics. The manufacturing landscape is highly competitive, with numerous global and regional players engaged in both active pharmaceutical ingredient (API) production and finished dosage development, contributing to a price-sensitive market environment.

Key Market Drivers

Growth in Healthcare Industry

The sustained expansion of the global healthcare industry is a key driver of the ibuprofen market. The U.S. alone spends nearly USD 3.5 trillion annually on healthcare, while healthcare expenditure in Europe comprises around 12% of GDP. In contrast, BRIC nations allocate an average of 6% of GDP to health services. This growing investment in healthcare infrastructure, combined with improved access to treatment and the increasing emphasis on affordable care, supports rising demand for over-the-counter and prescription medications like ibuprofen. Known for its anti-inflammatory, analgesic, and fever-reducing effects, ibuprofen remains a trusted first-line treatment option for mild to moderate pain and inflammatory conditions. Companies such as IOL Chemicals and Pharmaceuticals, which supplies about one-third of the global ibuprofen API, are expanding their product portfolios to meet growing demand fueled by the rising prevalence of lifestyle-related ailments like arthritis, chronic headaches, and musculoskeletal disorders.

Key Market Challenges

Safety & Side Effect Concerns

Despite its widespread usage and therapeutic benefits, ibuprofen faces notable challenges due to safety concerns and potential side effects. As an NSAID, ibuprofen is linked to gastrointestinal issues, particularly when used at high doses or over extended periods. Common side effects include stomach irritation, ulcers, and bleeding, which pose heightened risks for elderly patients or individuals with pre-existing GI conditions. In response, healthcare providers are increasingly recommending alternative treatments or co-prescribing gastroprotective agents to mitigate these risks. This shift in prescribing behavior could dampen demand for ibuprofen and encourage the use of other analgesic options, especially in vulnerable patient populations.

Key Market Trends

Expansion of E-Pharmacy

The growing prominence of e-pharmacy platforms is reshaping the global ibuprofen market by revolutionizing how medications are purchased and delivered. With digital transformation accelerating across the healthcare sector, online pharmacies are gaining traction as a preferred distribution channel for OTC medications like ibuprofen. Companies such as Amazon, Reliance, Tata 1mg, and PharmEasy are scaling operations in response to rising demand for convenience, competitive pricing, and timely access to medicines. In India, the e-pharmacy market was expected to expand sevenfold to USD 2.7 billion by 2023, reflecting broader shifts in consumer behavior and increased internet accessibility. This trend is enhancing market penetration, particularly in underserved regions, while also intensifying competition among digital pharmacy players seeking to dominate this growing segment.

Key Market Players

• Novartis AG
• Pfizer Inc.
• Abbott Laboratories Inc.
• Gilead Sciences Inc.
• Merck KGaA
• Astellas Pharma Inc.
• Glenmark Pharmaceuticals Ltd.
• NATCO Pharma Ltd.
• Basilea Pharmaceutical AG
• Leadiant Biosciences Inc.

Report Scope

In this report, the Global Ibuprofen Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ibuprofen Market, By Product Type:

• Tablet
• Capsule
• Syrup
• Injection

Ibuprofen Market, By Application:

• Rheumatoid Arthritis
• Ankylosing Spondylitis
• Inflammatory Diseases
• Dysmenorrhea
• Others

Ibuprofen Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ibuprofen Market.

Available Customizations

Global Ibuprofen Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Ibuprofen Market

5. Global Ibuprofen Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Tablet, Capsule, Syrup, Injection)
  • 5.2.2. By Application (Rheumatoid Arthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Ibuprofen Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ibuprofen Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Ibuprofen Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Ibuprofen Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application

7. Europe Ibuprofen Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Ibuprofen Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Ibuprofen Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Ibuprofen Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Ibuprofen Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Ibuprofen Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Ibuprofen Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ibuprofen Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Ibuprofen Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Ibuprofen Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Ibuprofen Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Ibuprofen Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application

9. South America Ibuprofen Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Ibuprofen Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Ibuprofen Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Ibuprofen Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Ibuprofen Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Ibuprofen Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Ibuprofen Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Ibuprofen Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Ibuprofen Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Novartis AG
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Pfizer Inc.
• 16.3. Abbott Laboratories Inc.
• 16.4. Gilead Sciences Inc.
• 16.5. Merck KGaA
• 16.6. Astellas Pharma Inc.
• 16.7. Glenmark Pharmaceuticals Ltd.
• 16.8. NATCO Pharma Ltd.
• 16.9. Basilea Pharmaceutical AG
• 16.10. Leadiant Biosciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer